"
Team Members
From 2008.igem.org
| Line 1: | Line 1: | ||
| - | == '''Prof. Dr. Roland Eils''' == | + | == '''Prof. Dr. Roland Eils''' == |
Thanks to Professor Eils, since he will sponsor travel/participation stipends for all undergraduate students on the team to attend the final jamboree at MIT. He will also provide R&D facilities and a team budget. Professor Eils is head of the Departments of Theoretical Bioinformatics in the institutes Bioquant, IPMB, and DKFZ. Moreover, he is founding director of Bioquant and directs the German-wide Systems Biology in Cancer initiative of the Helmholtz foundation with a volume of 50 Mio. Euro. Together with Professor Wolfrum he directs the Viroquant initiative on modeling and simulation of virus entry. He has won numerous awards in the field of image analysis; in particular he has been twice awarded the Biofuture price by the BMBF for innovations allowing the graphical reconstruction of the eukaryotic mitosis process from 4D microscopy images. In 2004, he was one of the organizers of the International Conference on Systems Biology, which was hosted by him here in Heidelberg. His publication with Martin Bentele, Inna Lavrik and Professor Krammer on the computational determination of the CD95 threshold in The Journal of Cell Biology in 2004 gave birth to the current Applied Systems Biology group, which is now largely involved in the research of cancer signaling. In 2004, Professor Eils, Ivayla Vacheva, and Professor Bock have won the Microsoft Research Award for the development of Optimal Experiment Design tools. His new engagement in the up-coming field of synthetic biology underlines the need for tight interdisciplinary work between experimentalists and theoreticians. | Thanks to Professor Eils, since he will sponsor travel/participation stipends for all undergraduate students on the team to attend the final jamboree at MIT. He will also provide R&D facilities and a team budget. Professor Eils is head of the Departments of Theoretical Bioinformatics in the institutes Bioquant, IPMB, and DKFZ. Moreover, he is founding director of Bioquant and directs the German-wide Systems Biology in Cancer initiative of the Helmholtz foundation with a volume of 50 Mio. Euro. Together with Professor Wolfrum he directs the Viroquant initiative on modeling and simulation of virus entry. He has won numerous awards in the field of image analysis; in particular he has been twice awarded the Biofuture price by the BMBF for innovations allowing the graphical reconstruction of the eukaryotic mitosis process from 4D microscopy images. In 2004, he was one of the organizers of the International Conference on Systems Biology, which was hosted by him here in Heidelberg. His publication with Martin Bentele, Inna Lavrik and Professor Krammer on the computational determination of the CD95 threshold in The Journal of Cell Biology in 2004 gave birth to the current Applied Systems Biology group, which is now largely involved in the research of cancer signaling. In 2004, Professor Eils, Ivayla Vacheva, and Professor Bock have won the Microsoft Research Award for the development of Optimal Experiment Design tools. His new engagement in the up-coming field of synthetic biology underlines the need for tight interdisciplinary work between experimentalists and theoreticians. | ||
| - | == '''Dr. Victor Sourjik''' == | + | == '''Dr. Victor Sourjik''' == |
Victor Sourjik has studied Molecular Biology and Physics at University of Regensburg. He has done his PhD at the Institute of Physics and Technology in Moskow and in the lab of Professor R. Schmitt at University of Regensberg. He then went as post-doctoral scientist for five years to Professor H. Berg at Harvard University in Cambridge, USA, and became group leader in 2003 at the Center for Molecular Biology in Heidelberg. Victor investigates bacterial chemotaxis as example for the molecular perception of environmental signals and their transduction within cells. He combines quantitative data with computational modeling to obtain a detailed understanding of the signaling mechanisms in complex systems. In his Nature publication in 2005 he could use criteria for systems robustness in order to predict a correct topology for the Che signal transduction network. This approach has become a paradigm for the utilization of systems biology to pursue biological research. For his successful research on prokaryotic signal transduction Victor has won the Chica and Heinz Schaller award in 2007. We are sure that his broad experience in the field of bacterial chemotaxis will be a key asset to the strength of our team. | Victor Sourjik has studied Molecular Biology and Physics at University of Regensburg. He has done his PhD at the Institute of Physics and Technology in Moskow and in the lab of Professor R. Schmitt at University of Regensberg. He then went as post-doctoral scientist for five years to Professor H. Berg at Harvard University in Cambridge, USA, and became group leader in 2003 at the Center for Molecular Biology in Heidelberg. Victor investigates bacterial chemotaxis as example for the molecular perception of environmental signals and their transduction within cells. He combines quantitative data with computational modeling to obtain a detailed understanding of the signaling mechanisms in complex systems. In his Nature publication in 2005 he could use criteria for systems robustness in order to predict a correct topology for the Che signal transduction network. This approach has become a paradigm for the utilization of systems biology to pursue biological research. For his successful research on prokaryotic signal transduction Victor has won the Chica and Heinz Schaller award in 2007. We are sure that his broad experience in the field of bacterial chemotaxis will be a key asset to the strength of our team. | ||
Revision as of 12:18, 4 August 2008
Prof. Dr. Roland Eils
Thanks to Professor Eils, since he will sponsor travel/participation stipends for all undergraduate students on the team to attend the final jamboree at MIT. He will also provide R&D facilities and a team budget. Professor Eils is head of the Departments of Theoretical Bioinformatics in the institutes Bioquant, IPMB, and DKFZ. Moreover, he is founding director of Bioquant and directs the German-wide Systems Biology in Cancer initiative of the Helmholtz foundation with a volume of 50 Mio. Euro. Together with Professor Wolfrum he directs the Viroquant initiative on modeling and simulation of virus entry. He has won numerous awards in the field of image analysis; in particular he has been twice awarded the Biofuture price by the BMBF for innovations allowing the graphical reconstruction of the eukaryotic mitosis process from 4D microscopy images. In 2004, he was one of the organizers of the International Conference on Systems Biology, which was hosted by him here in Heidelberg. His publication with Martin Bentele, Inna Lavrik and Professor Krammer on the computational determination of the CD95 threshold in The Journal of Cell Biology in 2004 gave birth to the current Applied Systems Biology group, which is now largely involved in the research of cancer signaling. In 2004, Professor Eils, Ivayla Vacheva, and Professor Bock have won the Microsoft Research Award for the development of Optimal Experiment Design tools. His new engagement in the up-coming field of synthetic biology underlines the need for tight interdisciplinary work between experimentalists and theoreticians.
Dr. Victor Sourjik
Victor Sourjik has studied Molecular Biology and Physics at University of Regensburg. He has done his PhD at the Institute of Physics and Technology in Moskow and in the lab of Professor R. Schmitt at University of Regensberg. He then went as post-doctoral scientist for five years to Professor H. Berg at Harvard University in Cambridge, USA, and became group leader in 2003 at the Center for Molecular Biology in Heidelberg. Victor investigates bacterial chemotaxis as example for the molecular perception of environmental signals and their transduction within cells. He combines quantitative data with computational modeling to obtain a detailed understanding of the signaling mechanisms in complex systems. In his Nature publication in 2005 he could use criteria for systems robustness in order to predict a correct topology for the Che signal transduction network. This approach has become a paradigm for the utilization of systems biology to pursue biological research. For his successful research on prokaryotic signal transduction Victor has won the Chica and Heinz Schaller award in 2007. We are sure that his broad experience in the field of bacterial chemotaxis will be a key asset to the strength of our team.
